The Times Australia
News From Asia

.
Times Media

.

Triastek's 3D Printed Gastric Retention Product T22 Receives FDA Clearance of IND Application

  • Triastek's 3D printed gastric retention product T22 received IND clearance from the FDA, becoming the world's first 3D printed gastric retention product.
  • Currently, Triastek has four 3D printed products, T19, T20, T21, and T22, that have obtained IND clearance from the FDA, ranking Triastek first in the global 3D printed field for pharmaceutical clinical development.

NANJING, CHINA - Media OutReach Newswire - 1 February 2024 - On January 27, Triastek announced that the U.S. Food and Drug Administration (FDA) granted clearance to proceed for the Investigational New Drug (IND) of the company's 3D-printed product T22, making it the first 3D printed gastric retention product to receive this designation. Triastek is preparing to initiate clinical studies with T22 to fast-track product development.

Triastek
Triastek's 3D Printed Gastric Retention Product T22 Receives FDA Clearance of IND Application

Triastek's T22 product is a 505(b)(2) product for the treatment of pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH). T22 is produced using Triastek's innovative Melt Extrusion Deposition plus Micro-Injection Molding (MED&MIM) process and utilizes its 3D Microstructure for Gastric Retention (3DμS®-GR) delivery technology platform. Compared with the current three times a day dosing of the originator product, T22 reduces the dosing frequency to once a day, simplifying the dosing regimen and improving medication adherence.

Dr. Senping Cheng, founder and CEO of Triastek, said: "Based on our proprietary 3D Microstructure for Gastric Retention delivery technology platform, the two products we developed, T20G and T22, have received IND clearance to proceed from regulatory agencies in China and the United States this year, marking the successful first step for Triastek's this innovative delivery technology platform proceeding through regulatory review process.

In 2021, Triastek and Sperogenix Therapeutics reached a co-development agreement regarding development and commercialization of T22 in East Asia to demonstrate the clinical application value of the 3D Microstructure Gastric Retention delivery technology. Based on the progress of T22, companies from several countries and regions have expressed interest in potential collaborations for product development utilizing this drug delivery technology platform."

Triastek has completed development of the T22 gastric retention formulation, achieved positive results in terms of in vitro expansion time, mechanical strength and dissolution behavior, and completed PK studies of the T22 gastric retention prototype in beagle dogs. Pharmacokinetic studies demonstrated that once daily dosing of the same total daily dose of the T22 gastric retention prototype gave comparable PK parameters, as TID dosing of the originator product.

With the FDA clearance to proceed with T22, this brings a total of four Triastek 3D-printed drug products, T19, T20, T21 and T22, to the clinical development stage, ranking first in the global 3D-printed drug field in terms of development product count. With the rapid advancement of the T-series pipeline and continuing validation of the clinical value of 3D printing drug technology, Triastek continues to develop new technologies and products for the global market. Currently our two key business models include "Product License-out Partnership" and "Technology Platform Partnership".

About Triastek's 3D Microstructure for Gastric Retention Delivery Technology Platform
A PCT application has been submitted for the 3D Microstructure for Gastric Retention delivery technology and its unique Bloom Structure design developed by Triastek. Upon oral administration, the gastric retention prototype expands to a size larger than the diameter of the pylorus, prolonging gastric retention time. During the gastric retention period, the prototype releases APIs according to a predetermined programmed drug release behavior. While simplifying the dosage regimen, reducing the medication burden, and improving the patient's long-term medication adherence, it can also improve drug absorption and oral bioavailability resulting in improved patient outcomes.

Hashtag: #Triastek#drug#3D-Printed

The issuer is solely responsible for the content of this announcement.

The Times Features

Group Adventures Made Easy: How to Coordinate Shuttle Services from DCA to IAD

Traveling as a large group can be both exciting and challenging, especially when navigating busy airports like DCA (Ronald Reagan Washington National Airport) and IAD (Washington...

From Anxiety to Assurance: Proven Strategies to Support Your Child's Emotional Health

Navigating the intricate landscape of childhood emotions can be a daunting task for any parent, especially when faced with common fears and anxieties. However, transforming anxie...

The Rise of Meal Replacement Shakes in Australia: Why The Lady Shake Is Leading the Pack

Source Meal replacement shakes are having a moment in Australia, and it’s not hard to see why. They’re quick, convenient, and packed with nutrition, making them the perfect solu...

HCF’s Healthy Hearts Roadshow Wraps Up 2024 with a Final Regional Sprint

Next week marks the final leg of the HCF Healthy Hearts Roadshow for 2024, bringing free heart health checks to some of NSW’s most vibrant regional communities. As Australia’s ...

The Budget-Friendly Traveler: How Off-Airport Car Hire Can Save You Money

When planning a trip, transportation is one of the most crucial considerations. For many, the go-to option is renting a car at the airport for convenience. But what if we told ...

Air is an overlooked source of nutrients – evidence shows we can inhale some vitamins

You know that feeling you get when you take a breath of fresh air in nature? There may be more to it than a simple lack of pollution. When we think of nutrients, we think of t...

Times Magazine

9 21st Century Skills Employers Seek In Business Professionals

The 21st century is like no other. It offers both risks and opportunities. It is incredibly competitive for business majors looking to expand their horizons. As a business graduate, you will succeed if you are aware of and possess the abilities t...

Benefits of building in timber frame

If you have a plan to do a home construction project, choose a solid and reliable timber frame for your best bet. A timber frame uses wood studs and rails with a sheathing board to create structural support for the uninitiated. But the myth is th...

Eliud Kipchoge signs with Shokz as global ambassador

Shokz, the consumer electronics brand, known for its open-ear headphones and technology, have today announced the current, two-time Olympic marathon champion, Eliud Kipchoge, as a global ambassador. As part of the partnership, Kipchoge and Shokz wi...

Why Every Construction Site Needs a Dust Extractor

Construction sites are full of dust. From concrete dust to sawdust and plaster, there is a lot of fine particles that can be hazardous for your health and the environment if not stored correctly. Dust extractors work to keep this dust at bay, ens...

A Fantastic Look Into The Top Fitness Trackers And Swimming Apps For 2022

People want swimming pools for several reasons and the best fibreglass pools today offer myriad advantages in your backyard. Anyone who gets a pool these days wants to swim in it for fun and fitness. Once you get a pool installed, you will likely u...

Beatbot - The ultimate pool cleaning solution

Pool maintenance is somewhere near the bottom of my priority list…until all of a sudden, spring arrives and the endless peppering from kids that want a non-stop pool-fest becomes part of the every day. It’s great fun when the pool is clean, clear...